EGFR Mutation Heterogeneity and the Mixed Response to EGFR Tyrosine Kinase Inhibitors of Lung Adenocarcinomas

Gelijkaardige items

• Intratumor Heterogeneity of ALK-Rearrangements and Homogeneity of EGFR-Mutations in Mixed Lung Adenocarcinoma
  door: Marino, Federica Zito, et al.
  Gepubliceerd in: (2015)
• EGFR mutation heterogeneity and mixed response to EGFR tyrosine kinase inhibitors of non small cell lung cancer: a clue to overcoming resistance
  door: Remon, Jordi, et al.
  Gepubliceerd in: (2013)
• Correction: Intratumor Heterogeneity of ALK-Rearrangements and Homogeneity of EGFR-Mutations in Mixed Lung Adenocarcinoma
  door: Zito Marino, Federica, et al.
  Gepubliceerd in: (2015)
• Micropapillary: A component more likely to harbour heterogeneous EGFR mutations in lung adenocarcinomas
  door: Cai, Yi-Ran, et al.
  Gepubliceerd in: (2016)
• Serial cfDNA assessment of response and resistance to EGFR-TKI for patients with EGFR-L858R mutant lung cancer from a prospective clinical trial
  door: Zhou, Qing, et al.
  Gepubliceerd in: (2016)